Hologic To Present at the Oppenheimer 4th Annual Mid and Small Cap 'Best Ideas' Conference
PRNewswire-FirstCall
BEDFORD, Mass.

BEDFORD, Mass., Oct. 21, 2008 /PRNewswire-FirstCall/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Oppenheimer 4th Annual Mid and Small Cap 'Best Ideas' Conference on November 18, 2008, at the Millennium Broadway Hotel in New York, NY.

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Tuesday, November 18, 2008, at 10:45 AM, EST on the investor section of the Company's website at http://www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including reagents for a variety of DNA and RNA analysis applications. For more information, visit http://www.hologic.com/.


Contact:
Deborah R. Gordon
Vice President, Investor Relations
Hologic, Inc.
Tel: 781.999.7716


Frances Doria
Director, Investor Relations
Hologic, Inc.
Tel: 781.999.7377